Kabra Drugs Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported net loss was INR 0.281 million compared to INR 0.035 million a year ago. Basic loss per share from continuing operations was INR 0.06 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.06 compared to INR 0.01 a year ago. For the six months, net loss was INR 0.897 million compared to INR 0.406 million a year ago. Basic loss per share from continuing operations was INR 0.2 compared to INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 0.2 compared to INR 0.09 a year ago.